LVHN Hit with $2.75M Fine for Drug Diversion Scheme

PHILADELPHIA, PA – A major crack in the system at Lehigh Valley Hospital Network (LVHN) has resulted in a $2,750,000 penalty for failing to secure its controlled substances, the U.S. Attorney’s Office announced today. The settlement stems from a series of alarming lapses that allowed a pharmacy technician to pilfer drugs and cover her tracks, exposing vulnerabilities within the hospital’s security protocols.

According to federal investigators, a pharmacy technician at LVHN’s Cedar Crest location brazenly used a colleague’s password to access and steal controlled substances on approximately 40 separate occasions. This wasn’t a simple grab-and-go; the technician allegedly fabricated reports to mask the missing drugs, creating a false paper trail designed to hide the discrepancies. The scheme went undetected for an unspecified period, highlighting a critical breakdown in oversight.

But the problem wasn’t limited to one rogue employee. The investigation revealed systemic failures in how LVHN managed the flow of controlled substances between its inpatient pharmacies, outpatient facilities, and hospice centers. Transfers lacked proper documentation, creating a breeding ground for potential theft and diversion. Investigators also found that LVHN failed to maintain accurate records of its drug inventory, further muddying the waters and hindering accountability.

U.S. Attorney David Metcalf minced no words, stating, “The U.S. Attorney’s Office is committed to aggressively combatting the opioid crisis…by holding hospitals and pharmacies responsible when they fail to take adequate steps to prevent controlled substances from being diverted for unlawful purposes.” While acknowledging the severity of the violations, Metcalf also noted that LVHN’s decision to self-report and cooperate with authorities played a role in mitigating the potential penalties.

Thomas Hodnett, Special Agent in Charge of the DEA’s Philadelphia Field Division, reinforced the message: “The Drug Enforcement Administration ensures that medical providers…follow established laws and procedures…This settlement demonstrates DEA’s resolve to maintain these standards.” LVHN claims to have already invested significant resources into bolstering security, implementing new training programs, and installing diversion-detection software in response to the findings.

The case was handled by Assistant U.S. Attorneys Peter Carr and Charlene Keller Fullmer, with assistance from former auditor Dawn Wiggins. It’s crucial to remember that the allegations outlined in the settlement have not been definitively proven in court, but the financial hit to LVHN serves as a stark warning: lax security when it comes to controlled substances will not be tolerated. This is a developing story, and Grimy Times will continue to follow the fallout.

RELATED: Lehigh Valley Hospital Network Hit with $2.75M Fine for Drug Thefts